Skip to content

What classification of medications is used for depression?

4 min read

Between 2015 and 2018, the percentage of U.S. adults taking an antidepressant medication was 13.2%, a significant increase from previous decades. The choice of treatment depends on understanding what classification of medications is used for depression and how each affects brain chemistry.

Quick Summary

Numerous classes of antidepressants are used to manage symptoms, with Selective Serotonin Reuptake Inhibitors (SSRIs) being the most common first-line treatment. Other options include Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), atypical antidepressants, and older, less-frequently used options like TCAs and MAOIs.

Key Points

  • SSRI Classification: SSRIs (e.g., fluoxetine, sertraline) are the most common first-line antidepressants, working by increasing serotonin levels in the brain.

  • SNRI Classification: SNRIs (e.g., duloxetine, venlafaxine) affect both serotonin and norepinephrine and are often prescribed for depression with associated pain or fatigue.

  • Atypical Antidepressants: This diverse class includes medications like bupropion and mirtazapine, which are used when other treatments fail or have undesirable side effects, such as sexual dysfunction.

  • Older Antidepressant Classes: TCAs and MAOIs are older classifications of medications used for depression that are typically reserved for treatment-resistant cases due to more significant side effects and interaction risks.

  • Personalized Treatment: The selection of an antidepressant depends on a patient's specific symptoms, tolerance for side effects, overall health, and history with past treatments.

  • Newer Options: Beyond traditional classifications, newer treatments like intranasal esketamine are available for adults with treatment-resistant depression.

In This Article

Introduction to Antidepressant Classifications

Antidepressants work by adjusting the balance of key neurotransmitters, the chemical messengers in the brain. Symptoms of depression are often associated with imbalances in these brain chemicals, particularly serotonin, norepinephrine, and dopamine. While all antidepressant medications share the goal of regulating mood, they accomplish this through different mechanisms, leading to their classification into several distinct categories. The choice of medication is a complex decision made by a healthcare provider, taking into account a patient's specific symptoms, potential side effects, and any history of treatment.

Selective Serotonin Reuptake Inhibitors (SSRIs)

SSRIs are the most frequently prescribed type of antidepressant and are often a first-line treatment due to their effectiveness and generally fewer side effects compared to older medications. These medications work by preventing the reuptake, or reabsorption, of serotonin by neurons in the brain. This increases the concentration of serotonin in the synaptic cleft—the space between neurons—allowing it to remain active for longer and enhancing mood transmission. Common examples of SSRIs include fluoxetine (Prozac), sertraline (Zoloft), escitalopram (Lexapro), citalopram (Celexa), and paroxetine (Paxil). Side effects, which often improve within the first few weeks, can include gastrointestinal issues, headache, and sexual dysfunction.

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

SNRIs operate similarly to SSRIs but affect two neurotransmitters: serotonin and norepinephrine. By blocking the reuptake of both chemicals, SNRIs can help regulate mood, reduce anxiety, and alleviate physical symptoms of depression. This dual mechanism of action may make them effective for people who also experience pain or fatigue related to their depression. Popular SNRIs include venlafaxine (Effexor XR), duloxetine (Cymbalta), and desvenlafaxine (Pristiq). Side effects can overlap with SSRIs but may also include dry mouth and increased blood pressure or heart rate. Abrupt discontinuation can also lead to more pronounced withdrawal-like symptoms compared to SSRIs.

Atypical Antidepressants

This is a diverse group of medications that do not fit neatly into other classes and have unique mechanisms of action. They are often prescribed when other options are ineffective or cause undesirable side effects. Examples include:

  • Bupropion (Wellbutrin): A norepinephrine and dopamine reuptake inhibitor that is less associated with sexual side effects and weight gain. It is also used for seasonal affective disorder and smoking cessation.
  • Mirtazapine (Remeron): Works by blocking specific receptors to increase norepinephrine and serotonin release. It is often prescribed for individuals with insomnia or appetite loss related to depression due to its sedative effects.
  • Trazodone: Primarily used as a serotonin modulator but also functions differently than SSRIs and SNRIs. It is often used off-label for treating insomnia.

Tricyclic Antidepressants (TCAs)

TCAs were among the first antidepressants but are less commonly prescribed today because of their higher risk of side effects and cardiotoxicity, especially in cases of overdose. They work by increasing the levels of both serotonin and norepinephrine in the brain, much like SNRIs, but are less selective. Examples include amitriptyline (Elavil), nortriptyline (Pamelor), and imipramine (Tofranil). Given their side effect profile, they are usually reserved for cases where newer antidepressants have failed. Common side effects include dry mouth, constipation, blurry vision, and dizziness.

Monoamine Oxidase Inhibitors (MAOIs)

MAOIs are another older class of antidepressants that are typically used when other treatments have been unsuccessful. They function by inhibiting monoamine oxidase, an enzyme that breaks down neurotransmitters like serotonin and norepinephrine. While effective, MAOIs require strict dietary restrictions, particularly avoiding foods containing high levels of tyramine (e.g., aged cheeses, cured meats), to prevent dangerously high blood pressure. They also have potentially serious interactions with other medications. Examples include phenelzine (Nardil) and tranylcypromine (Parnate).

Comparison of Major Antidepressant Classifications

Classification Mechanism of Action Common Side Effects Use Case Examples
SSRIs Blocks serotonin reuptake, increasing serotonin levels. Nausea, sexual dysfunction, headaches, insomnia. First-line treatment for depression and anxiety. Sertraline, Fluoxetine, Escitalopram.
SNRIs Blocks both serotonin and norepinephrine reuptake. Dry mouth, nausea, high blood pressure, withdrawal symptoms. Effective for depression, especially with associated fatigue or pain. Duloxetine, Venlafaxine.
Atypical Diverse mechanisms; affect dopamine and/or norepinephrine. Varies widely; bupropion has fewer sexual side effects; mirtazapine can cause weight gain. Used when other medications are ineffective or cause unwanted side effects. Bupropion, Mirtazapine, Trazodone.
TCAs Blocks reuptake of serotonin and norepinephrine, less selectively than SNRIs. Drowsiness, dry mouth, constipation, dizziness, cardiotoxicity risk. Older class, reserved for treatment-resistant cases due to side effects. Amitriptyline, Nortriptyline.
MAOIs Inhibits monoamine oxidase, preventing neurotransmitter breakdown. Serious food and drug interactions; dietary restrictions necessary. Older class, typically used for treatment-resistant depression. Phenelzine, Isocarboxazid.

Choosing the Right Antidepressant

  • Symptom Profile: Different medications target specific symptoms. For example, some SNRIs may be better for patients with comorbid pain, while mirtazapine may help those with significant sleep and appetite issues.
  • Side Effect Tolerance: A patient's ability to tolerate specific side effects, such as sexual dysfunction or weight gain, is a major factor in selection. A provider may choose an atypical antidepressant like bupropion if sexual side effects are a concern.
  • Coexisting Conditions: Other medical conditions, such as heart problems, must be considered, especially with older drugs like TCAs. Interactions with other medications are also critical, particularly with MAOIs.
  • Family History: A family member's positive response to a particular medication may suggest a higher likelihood of success for the patient.
  • Cost and Access: The cost of a medication and availability of generic formulations can influence the choice, as many older antidepressants are available generically.

Conclusion

Understanding the various classifications of medications used for depression, including SSRIs, SNRIs, atypical antidepressants, TCAs, and MAOIs, is crucial for both patients and healthcare providers. While SSRIs and SNRIs are most common, other classifications offer valuable alternatives, particularly for treatment-resistant cases. Newer treatments like esketamine are also expanding the options for managing complex depression. The ultimate goal is to find the right therapeutic fit, a process that requires patience and a collaborative approach with a healthcare professional. For more information on pharmacologic treatments, authoritative resources like the American Academy of Family Physicians provide detailed guidelines.

Frequently Asked Questions

The most commonly prescribed classification of medication for depression is Selective Serotonin Reuptake Inhibitors, or SSRIs.

An SSRI blocks the reuptake of serotonin only, while an SNRI blocks the reuptake of both serotonin and norepinephrine.

Tricyclic Antidepressants (TCAs) are prescribed less often because they tend to have more bothersome and potentially serious side effects than newer antidepressants like SSRIs.

Common side effects of SSRIs can include nausea, headache, sleep problems, weight changes, and sexual dysfunction, though many side effects may lessen over time.

Yes, Monoamine Oxidase Inhibitors (MAOIs) require a strict diet. This is because they can cause dangerous and potentially deadly interactions with foods that contain high levels of tyramine.

No, you should not stop taking antidepressants suddenly without talking to your healthcare provider. Abruptly stopping can cause withdrawal-like symptoms, known as antidepressant discontinuation syndrome.

Yes, newer treatments are available, including medications like vilazodone and vortioxetine, and fast-acting options for treatment-resistant depression like intranasal esketamine.

A doctor considers many factors, including your specific symptoms, the presence of other medical conditions, potential side effects, cost, and any family history of antidepressant response.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.